Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Strong Buy

Standard Deviation

Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Biofrontera Inc. Common Stock (BFRI)

Pharmaceutical Preparations

https://www.biofrontera-us.com

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.

120 PRESIDENTIAL WAY,, SUITE 330
WOBURN, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/29/2021

Market Cap

6,209,083

Shares Outstanding

1,520,000

Weighted SO

1,517,628

Total Employees

N/A

Upcoming Earnings

08/09/2024

Beta

0.4700

Last Div

0.0000

Range

0.61-9.7

Chg

0.0500

Avg Vol

70896

Mkt Cap

6209083

Exch

NASDAQ

Country

US

Phone

781 245 1325

DCF Diff

N/A

DCF

0.0000

Div Yield

0.0000

P/S

0.1763

EV Multiple

-0.1775

P/FV

0.5693

Div Yield %

0.0000

P/E

-0.4598

PEG

-0.0488

Payout

0.0000

Current Ratio

1.8851

Quick Ratio

1.4593

Cash Ratio

0.4725

DSO

36.3186

DIO

77.6227

Op Cycle

113.9414

DPO

92.0221

CCC

21.9193

Gross Margin

0.4731

Op Margin

-0.5402

Pretax Margin

-0.3832

Net Margin

-0.3836

Eff Tax Rate

-0.0012

ROA

-0.6262

ROE

-4.7713

ROCE

-1.5458

NI/EBT

1.0012

EBT/EBIT

0.7094

EBIT/Rev

-0.5402

Debt Ratio

0.0667

D/E

0.1320

LT Debt/Cap

0.0390

Total Debt/Cap

0.1166

Int Coverage

9.9493

CF/Debt

-13.1354

Equity Multi

1.9773

Rec Turnover

10.0499

Pay Turnover

3.9664

Inv Turnover

4.7022

FA Turnover

26.4576

Asset Turnover

1.6323

OCF/Share

-3.7151

FCF/Share

-3.7249

Cash/Share

0.8620

OCF/Sales

-0.5371

FCF/OCF

1.0026

CF Coverage

-13.1354

ST Coverage

-18.9719

CapEx Coverage

-378.3000

Div&CapEx Cov

-378.3000

P/BV

0.5693

P/B

0.5693

P/S

0.1763

P/E

-0.4598

P/FCF

-0.3274

P/OCF

-0.3284

P/CF

-0.3284

PEG

-0.0488

P/S

0.1763

EV Multiple

-0.1775

P/FV

0.5693

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation